Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
American Family Physician
|
December 18, 2003
No data to show link between opioid abuse and heroin use
Erik W Gunderson
Substance Abuse
|
March 27, 2015
Recognizing Potential Buprenorphine Medication Misuse: Product Packaging Does Not Degrade With Laundering
Erik W Gunderson
Journal of Addiction Medicine
|
October 27, 2011
Buprenorphine induction: a major barrier for physician adoption of office-based opioid dependence treatment
Erik W Gunderson
Annals of Internal Medicine
|
September 11, 2013
Synthetic cannabinoids: a new frontier of designer drugs
Erik W Gunderson
Journal of Addiction Medicine
|
February 27, 2016
Efficacy of Buprenorphine/Naloxone Rapidly Dissolving Sublingual Tablets (BNX-RDT) After Switching From BNX Sublingual Film
Erik W Gunderson, Michael Sumner
CNS Drugs
|
January 16, 2008
Office-based maintenance treatment of opioid dependence: how does it compare with traditional approaches?
Erik W Gunderson, David A Fiellin
American Family Physician
|
April 27, 2012
Evaluation of chronic cough should consider cannabis use
Glen P Davis, Erik W Gunderson
Clinical Therapeutics
|
September 29, 2015
Effects of a higher-bioavailability buprenorphine/naloxone sublingual tablet versus buprenorphine/naloxone film for the treatment of opioid dependence during induction and stabilization: a multicenter, randomized trial
Erik W Gunderson, Peter Hjelmström, Michael Sumner, et al.
Journal of Addictive Diseases
|
March 24, 2005
Screening and intervention for alcohol and illicit drug abuse:a survey of internal medicine housestaff
Erik W Gunderson, Frances R Levin, Lawrence Smith
The American Journal on Addictions
|
April 9, 2008
Impact of a brief training on medical resident screening for alcohol misuse and illicit drug use
Erik W Gunderson, Frances R Levin, Patricia Owen
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
American Family Physician
|
December 18, 2003
No data to show link between opioid abuse and heroin use
Erik W Gunderson
Substance Abuse
|
March 27, 2015
Recognizing Potential Buprenorphine Medication Misuse: Product Packaging Does Not Degrade With Laundering
Erik W Gunderson
Journal of Addiction Medicine
|
October 27, 2011
Buprenorphine induction: a major barrier for physician adoption of office-based opioid dependence treatment
Erik W Gunderson
Annals of Internal Medicine
|
September 11, 2013
Synthetic cannabinoids: a new frontier of designer drugs
Erik W Gunderson
Journal of Addiction Medicine
|
February 27, 2016
Efficacy of Buprenorphine/Naloxone Rapidly Dissolving Sublingual Tablets (BNX-RDT) After Switching From BNX Sublingual Film
Erik W Gunderson, Michael Sumner
CNS Drugs
|
January 16, 2008
Office-based maintenance treatment of opioid dependence: how does it compare with traditional approaches?
Erik W Gunderson, David A Fiellin
American Family Physician
|
April 27, 2012
Evaluation of chronic cough should consider cannabis use
Glen P Davis, Erik W Gunderson
Clinical Therapeutics
|
September 29, 2015
Effects of a higher-bioavailability buprenorphine/naloxone sublingual tablet versus buprenorphine/naloxone film for the treatment of opioid dependence during induction and stabilization: a multicenter, randomized trial
Erik W Gunderson, Peter Hjelmström, Michael Sumner, et al.
Journal of Addictive Diseases
|
March 24, 2005
Screening and intervention for alcohol and illicit drug abuse:a survey of internal medicine housestaff
Erik W Gunderson, Frances R Levin, Lawrence Smith
The American Journal on Addictions
|
April 9, 2008
Impact of a brief training on medical resident screening for alcohol misuse and illicit drug use
Erik W Gunderson, Frances R Levin, Patricia Owen
Page
of 4